Cargando…
Congenital Heart Disease: The State-of-the-Art on Its Pharmacological Therapeutics
Congenital heart disease is one of the most common causes of death derived from malformations. Historically, its treatment has depended on timely diagnosis and early pharmacological and surgical interventions. Survival rates for patients with this disease have increased, primarily due to advancement...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316572/ https://www.ncbi.nlm.nih.gov/pubmed/35877563 http://dx.doi.org/10.3390/jcdd9070201 |